Wyeth Sets Up Its Globally First Clinical Research Center
Posted on: Sunday, 26 March 2006, 12:00 CST
According to fdi.gov.cn: Wyeth, which enjoys great fame in China for its milk powder, is trying to shift its priority to prescription drugs. Yesterday, Early Clinical Drug Research Center came into being in Beijing, a cooperative product of Wyeth and Peking Union Medial College Hospital
. This is Wyeth's globally first clinical research center. Wyeth is ranked ninth in the global prescription drug market. It introduced its milk powder products to China in 1990, but didn't find its way into China's prescription drug market until 1998. Therefore, its performance in China's milk powder and nutritional products market by far outshines that in China's drug market.Source: Info-Prod Research (Middle East)
Related Articles
- China's Breast Cancer Drug Market Will Grow From $165 Million in 2008 to $298 Million In 2013
- China Announced Second Infant Death From Tainted Milk Powder
- China's Hepatitis B Virus Drug Market Will Grow to $800 Million By 2012
- China's Renal Cell Carcinoma Drug Market Will Grow More Than Five-Fold By 2012
- Emergence of Drugs From Elan/Wyeth, Eli Lilly, Myriad Genetics and Medivation Will Drive the Alzheimer's Disease Drug Market to Nearly Triple By 2017
- China's Gastric Cancer Drug Market to Triple By 2012, Says Report
- New Guidebook Essential Reading for Companies Wishing to Enter China's Lucrative Drug Market
- Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
- China rejects 100 metric tons of US milk powder
- Research and Markets: Worldwide Prescription Drug Market for Women's Health Forecast to Grow to $11.6 Billion in 2009
Rating: 2.5 / 5 (6 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds